ZIVO regains Nasdaq compliance after late 10-K filing cured

Zivo Bioscience, Inc.

Received noncompliance notice on April 19, 2022 for failing to timely file 2021 10-K.
Filed the Form 10-K on April 22, 2022 to regain compliance.
Nasdaq confirmed compliance regained on April 25, 2022 and closed the matter.
No immediate effect on listing or trading of common stock during the notice period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.